Veraxa Biotech Holding AG carries a market capitalization of 610.74M, placing it among publicly traded companies globally.
| Market Cap | 610.74M |
| Enterprise Value | N/A |
Veraxa Biotech Holding AG's stock has declined approximately -63.42857% over the past 52 weeks. The 50-day moving average sits at 12.13, while the 200-day moving average is 11.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | -63.42857% |
| 50-Day Moving Average | 12.13 |
| 200-Day Moving Average | 11.07 |
| Average Volume (20 Days) | N/A |